Bruce Y. Lee

Cost-effectiveness of candidate adjuvanted subunit vaccine for vaccinating U.S. adults not previously vaccinated against herpes zoster

B. Yawn, B. Patterson, P. Buck, 2017 .

Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine live

B. Yawn, B. Patterson, P. Buck, 2019, Human vaccines & immunotherapeutics.

Assessment of the Potential Herpes Zoster and Post Herpetic Neuralgia Case Avoidance with Vaccination in the United States

B. Yawn, J. Pawlowski, B. Patterson, 2017, Open Forum Infectious Diseases.

Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in older adults in the United States.

B. Yawn, B. Patterson, P. Buck, 2018, Vaccine.

Meeting Abstracts - Academy of Managed Care Pharmacy Nexus 2017.

L. Varghese, J. Carrico, Bruce Y. Lee, 2017, Journal of managed care & specialty pharmacy.